HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Romina Nassini Selected Research

ibuprofen acyl glucuronide

1/2019The acyl-glucuronide metabolite of ibuprofen has analgesic and anti-inflammatory effects via the TRPA1 channel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Romina Nassini Research Topics

Disease

31Pain (Aches)
01/2022 - 08/2007
23Hyperalgesia
01/2022 - 06/2010
11Neoplasms (Cancer)
10/2022 - 05/2013
11Melanoma (Melanoma, Malignant)
10/2022 - 09/2014
10Migraine Disorders (Migraine)
01/2022 - 01/2010
10Inflammation (Inflammations)
02/2020 - 08/2007
10Neurogenic Inflammation
09/2019 - 08/2007
9Neuralgia (Stump Neuralgia)
12/2019 - 03/2012
5Headache (Headaches)
01/2022 - 02/2012
5Hypersensitivity (Allergy)
01/2020 - 08/2007
4Cancer Pain
01/2021 - 01/2019
4Edema (Dropsy)
12/2018 - 12/2010
3Cough
01/2021 - 01/2010
3Neuroinflammatory Diseases
01/2021 - 12/2017
3Cold Hypersensitivity
12/2020 - 07/2011
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 08/2021
2Carcinogenesis
11/2021 - 09/2014
2Breast Neoplasms (Breast Cancer)
11/2021 - 12/2014
2Acute Pain
02/2020 - 08/2007
2Ischemia
01/2020 - 01/2020
2Pulmonary Hypertension
12/2019 - 05/2019
2Pruritus (Itching)
12/2014 - 04/2013
2Gout
07/2014 - 11/2013
2Chronic Obstructive Pulmonary Disease (COPD)
04/2014 - 12/2010
2Asthma (Bronchial Asthma)
04/2014 - 12/2010
2Peripheral Nervous System Diseases (PNS Diseases)
05/2013 - 04/2012
2Vitiligo
06/2009 - 01/2009
1Relapsing-Remitting Multiple Sclerosis
01/2022
1Pigmented Nevus (Melanocytic Nevus)
11/2021
1Dysplastic Nevus Syndrome (Dysplastic Nevus)
11/2021
1Multiple Sclerosis
08/2021
1Toothache (Toothaches)
02/2020

Drug/Important Bio-Agent (IBA)

34AnkyrinsIBA
01/2022 - 01/2010
16TRPA1 Cation ChannelIBA
11/2021 - 08/2008
8Calcitonin Gene-Related PeptideIBA
01/2022 - 03/2008
7Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
11/2021 - 11/2013
7Ion Channels (Ion Channel)IBA
08/2021 - 03/2008
7Irritants (Vesicants)IBA
09/2019 - 08/2007
7NeuropeptidesIBA
01/2019 - 08/2007
72- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA
01/2019 - 07/2011
6Pharmaceutical PreparationsIBA
01/2018 - 05/2010
5AntioxidantsIBA
12/2020 - 04/2012
4CytokinesIBA
01/2022 - 01/2009
4Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021 - 08/2007
44-hydroxy-2-nonenal (4-hydroxynonenal)IBA
11/2021 - 08/2007
4Formaldehyde (Formol)FDA Link
01/2020 - 02/2012
4Thioctic Acid (Lipoic Acid)IBA
01/2020 - 05/2013
4Substance PIBA
01/2017 - 03/2008
4Capsaicin (Zostrix)FDA Link
11/2013 - 07/2008
4Acrolein (Aqualin)IBA
01/2012 - 08/2007
3Adrenergic Receptors (Adrenergic Receptor)IBA
01/2021 - 03/2015
3CationsIBA
10/2020 - 07/2011
3CarrageenanIBA
02/2020 - 07/2015
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2019 - 01/2017
3Transient Receptor Potential ChannelsIBA
09/2019 - 03/2008
3Dinoprostone (PGE2)FDA Link
02/2019 - 07/2015
3Bortezomib (Velcade)FDA Link
01/2017 - 05/2013
3Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2013 - 07/2011
3SmokeIBA
02/2012 - 07/2008
2Monoclonal AntibodiesIBA
01/2022 - 01/2019
2CalciumIBA
11/2021 - 06/2010
2Propranolol (Inderal)FDA LinkGeneric
01/2021 - 03/2015
2Anesthetics (Anesthetic Agents)IBA
02/2020 - 06/2010
2ParaffinIBA
01/2020 - 01/2017
2rho-Associated KinasesIBA
12/2019 - 05/2019
2MonocrotalineIBA
12/2019 - 05/2019
2Protein Kinases (Protein Kinase)IBA
12/2019 - 05/2019
2NADP (NADPH)IBA
12/2019 - 01/2016
2CateninsIBA
11/2019 - 01/2017
2Biomarkers (Surrogate Marker)IBA
11/2019 - 09/2014
2Peptides (Polypeptides)IBA
02/2019 - 01/2017
2NADPH Oxidases (NAD(P)H oxidase)IBA
01/2019 - 12/2018
2Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
01/2019 - 01/2018
2Aromatase InhibitorsIBA
12/2016 - 12/2014
2Bile Acids and Salts (Bile Acids)IBA
12/2014 - 04/2013
2Messenger RNA (mRNA)IBA
09/2014 - 01/2009
2Uric Acid (Urate)IBA
07/2014 - 11/2013
2AldehydesIBA
07/2008 - 08/2007
1NAD (NADH)IBA
10/2022
1Nicotinamide PhosphoribosyltransferaseIBA
10/2022
1Dronabinol (THC)FDA LinkGeneric
10/2022
1EnzymesIBA
10/2022
1Melanins (Melanin)IBA
01/2022
1Calcitonin Receptors (Calcitonin Receptor)IBA
01/2022
1Receptor Activity-Modifying Protein 1IBA
01/2022
1Macrophage Colony-Stimulating FactorIBA
01/2021
1NociceptinIBA
01/2021
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
01/2021
1Nociceptin ReceptorIBA
01/2021
13- (2- ethylphenoxy)- 1- (1,2,3,4- tetrahydronaphth- 1- ylamino)- 2- propanol oxalateIBA
01/2021
1Biological ProductsIBA
01/2021
1Atenolol (Tenormin)FDA LinkGeneric
01/2021
1Antitussive Agents (Antitussives)FDA Link
01/2021
1Thalidomide (Thalomid)FDA Link
12/2020
1pomalidomideIBA
12/2020
1Lenalidomide (CC 5013)FDA Link
12/2020
1HexanesIBA
02/2020

Therapy/Procedure

7Therapeutics
10/2022 - 12/2014
2Drug Therapy (Chemotherapy)
01/2020 - 05/2013
2Ligation
12/2017 - 07/2015